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Stimulation 
Objectives. The purpose of this study was to 1) develop an 
animal model of hibernating myocardium, and 2) evaluate the 
ability of dobntamine stimulation to detect hibernating myocar- 
dium using both qualitative and quantitative assessment of re- 
gional myocardial function. 
Background. Left ventricular dysfunction may be due to chronic 
ischemia with or without myocardial infarction and may improve 
after coronary blood flow is enhanced by revascularization proce- 
dures. This condition has been coined "hibernating myocardium" 
and variably defined in recent years. The results of recent clinical 
studies uggest that dobutamine echocardiography may be useful 
for detecting viable myocardium in patients with left ventricnlar 
dysfunction. 
Methods. Twenty-one dogs underwent initial operation. 
Sonomicrometer crystals were implanted, and baseline measure- 
ments of segment shortening and wall thickening (by echocardi. 
ography) were made. A coronary artery was ligated; the chest was 
closed; and measurements were repeated. Dobutamine was incre- 
mentally infused with determination ofwall thickening and seg- 
ment shortening at baseline and on days 3 and 7 and weeks 2 and 
4 after coronary artery occlusion. Finally, the chest was reopened; 
the ligated vessel was bypassed; and measurements were repeated. 
Results. Of the 10 dogs that completed the entire protocol, 7 
had varying degrees of nontransmural myocardial infarction 
(group 1), and 3 had complete transmural myocardial infarction 
(group 2). In group 1, baseline function was significantly impaired 
compared with preligation function but increased uring dobut- 
amine infusion. When reperfused after 4 weeks, both wall thick- 
ening and segment shortening increased significantly. In group 2, 
significant changes were not seen during the dobutamine studies 
or after reperfusion. Myocardial perfusion during dobutamine 
infusion increased in group 1 but did not change in group 2. 
Conclusions. We demonstrated improvement in chronically 
dysfunctional myocardium after restoration of previously inter- 
rupted myocardial blood flow in dogs after nontransmural myo- 
cardial infarction, thus validating a canine model of hibernating 
myocardium. As assessed by two independent methods, dobut- 
amine infusion identified hibernating myocardium in an animal 
model. 
(J Am Coil Cardiol 1995;26:1348-55) 
In recent years, the state of dysfunctional but viable myocar- 
dium has been increasingly accepted as an important clinical 
entity on the basis of clinical and experimental observations 
(1-3). Left ventricular dysfunction may be due to chronic 
ischemia with or without myocardial infarction and may im- 
prove when coronary blood flow is increased by revasculariza- 
tion procedures (3-10). In 1985, Rahimtoola (5) used the term 
"hibernating myocardium" todescribe this phenomenon. This 
term is most often used in the setting of persistent left 
ventricular dysfunction caused by reduced myocardial perfu- 
sion that is sufficient o prevent irreversible cell damage but 
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inadequate omeet demands for contractile function (1,2,11). 
When perfusion is restored, an immediate increase in myocar- 
dial contractile function has been described (6,7,9). 
Several methods have been proposed to assess hibernating 
myocardium. One of the most established ispositron emission 
tomography. Investigators have demonstrated that a "mis- 
match pattern" of reduced blood flow (as assessed by perfusion 
tracers) and normal or increased fluorine-18 deoxyglucose 
uptake indicate the presence of viable myocardium. Several 
studies (2,3,8-10) have correlated this positron emission to- 
mographic finding with improved myocardial contractility after 
restoration of myocardial blood flow. 
The effect of catecholamine stimulation on hibernating 
myocardium has been partially evaluated (12). Cigarroa et al. 
(13) found dobutamine stress echocardiograpfiy useful in 
detecting functional recovery in myocardial function in a 
subset of patients after coronary artery revascularization. La 
Canna et al. (14) evaluated low dose dobutamine infusion in a 
group of patients with akinetic wall motion at rest. In their 
study, dobutamine stress echocardiography had a sensitivity of 
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Figure 1. Experimental protocol. The time intervals are displayed 
below, and the interventions above, the time line. DOB = dobutamine 
infusion; MBF = injection of radiolabeled microspheres; MI = 
myocardial infarction. 
86.8% for the detection of improved wall motion after revas- 
cularization. 
The majority of the clinical studies published to date have 
involved heterogeneous patient groups or patients with a 
myocardial infarction. All the clinical studies have used only 
qualitative assessment ofmyocardial function. The purpose of 
the present study was 1) to establish an animal model of 
hibernating myocardium, and 2) to quantitatively study the 
effects of dobutamine stimulation on hibernating myocardium. 
Methods 
The study was approved by the Indiana University. School of 
Medicine Animal Care Committee, and all dogs were main- 
tained in accordance with its guidelines for humane treatment 
of laboratory animals. 
Initial animal preparation. A scheme of the study protocol 
is shown in Figure 1. The study was performed using 21 male 
or female dogs weighing 12 to 31 kg (mean [+SD] 20 _+ 4.7 kg). 
Dogs were initially anesthetized with thiopental sodium 
(25 mg/kg body weight). After endotracheal intubation, 
anesthesia was maintained with isoflurane (100% oxygen, 
1.0 to 1.75 vol/100 ml isoflurane) and mechanical ventilation 
(Metomatic veterinary ventilator, Ohio Medical). Long- and 
short-axis parasternal echocardiographic views (ATL UM 4, 
5.0-MHz transducer, Bothell) were obtained through acutout 
in the table with the dog lying on its right side. The images 
were digitized on-line (Microsonics PreView, Mahwah) and 
videotaped on VHS video. Under sterile conditions, a left 
thoracotomy was performed, the pericardium incised and the 
heart exposed. Paired sonomicrometer crystals (Triton Tech- 
nology) were implanted in the subendocardial layer of the 
myocardium, with one pair located in the distribution of the 
left circumflex coronary artery and a second pair in the dis- 
tribution of the left anterior descending coronary artery. At the 
site of their epicardial exit, each crystal wire was attached by a 
suture to the epicardial surface to avoid dislocation. After the 
crystals were placed and initial measurements obtained, amajor 
epicardial artery was ligated. Measurements were repeated, and 
the chest was closed. The wires of the sonomicrometer crystals 
were tunneled subcutaneously for -20 to 25 cm and exited on the 
dorsal aspect of the dog. One hour after coronary artery occlu- 
sion, echocardiographic imaging and sonomicrometric measure- 
ments were repeated. The dogs received buprenorphine 
(0.02 mg/kg) for 2 days, penicillin G (200,000 U) on the day of 
operation (200,000 U) and cefazolin (2 g/day) for 3 days postop- 
eratively. 
Dobntamine studies. Each dog underwent dobutamine 
echocardiography and sonomicrometric measurements a  day 
3 and weeks 1, 2 and 4 after the initial operation (Fig. 1). 
Anesthesia was induced with thiopental sodium and main- 
tained with isoflurane after endotracheal intubation. Echocar- 
diographic images were obtained at baseline and at the follow- 
ing infusion rates: 2.5, 5, 10, 20 and 30 p,g/kg per min. The 
infusion was increased every 3 min. The drug was delivered 
through an antebrachial vein by a preprogrammed (for all 
stages) injection device (Harvard Apparatus "22" Syringe 
Pump). Sonomicrometer crystal wires were connected and 
calibrated and measurements were taken as previously de- 
scribed. Electrocardiographic (ECG) electrodes were placed at 
the extremities. 
Final surgical procedure at 4 weeks. Dobutamine echocar- 
diography was performed as previously described. Catheters 
were then placed in the femoral artery (for pressure measure- 
ments and for blood withdrawal) and in the femoral vein (for 
administration f medications). A left lateral thoracotomy was 
performed, a microtipped pressure transducer (Millar) was 
inserted through the left atrial appendage into the left ventricle 
for measurement of left ventricular pressure and its first 
de rivative (dP/dt). A left atrial catheter was placed through the 
same incision for injection of radioactive microspheres. 
After calibration of the transducer, a second dobutamine 
infusion was administered as previously described, and 
sonomicrometric measurements and left ventricular and arte- 
rial pressures were recorded. Radioactive microspheres 
(cobalt-51, tin-ll3, ruthenium-103 and niobium-95; New En- 
gland Nuclear) were injected before and during the dobut- 
amine infusion. 
The site of the coronary artery ligation was then exposed. 
The ligation was removed and the vessel inspected for spon- 
taneous filling. Sonomicrometric and pressure measurements 
were recorded -5 to 10 min after the ligation was removed. 
The coronary artery was incised proximal to the former site of 
[igation, and a cannula was inserted and directed anterograde 
through the site of the previous ligation. A cannula had been 
previously inserted in the right carotid artery and connected to
a roller pump (Harvard "66" Peristaltic Pump). After connec- 
tion to the coronary cannula, flow was started at the rate of 7.5 
to 12.0 ml/min and maintained for 1 h. During this time, 
echocardiographic and sonomicrometric measurements were 
taken as previously described at 5, 30 and 60 min. 
The heart was then excised, sliced in 1-cm slices at different 
short-axis levels and incubated for 15 min in a buffered 1% 
triphenyltetrazolium chloride solution, resulting in a dark red 
color in viable areas and a pale tan color for infarcted 
myocardium. The slices were then photographed, and the 
infarct size was planimetered to determine the percent of 
infarcted tissue. The transmural extent of the infarction was 
then determined by measuring the percent thickness of viable 
myocardium in the center of the infarct zone. 
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Table 1. Results for Group 1 Dogs 
Sonomicrometu, Echocardiography 
Baseline Dobutam ine Baseline Dobutamine 
Study ~~ SS ~ Base % SS ~ Base % WT % Base % WT % Base 
Preocclusion 15 + 6* 100 21 _+ 3* 100 
lh  -3=3"  19-3  -15=10"  -70_+59 
3 d 2 + 9 29 = 56 13 ± 3 ~4 v 3S -8  ± 4 -39 ± 24 32-+ 14 154-+ 59 
7 d 4 + 2 411 +_ 32 10 + 2 82 ± 3!~ -2 ± 5 -5  -+ 26 29-+ 10 146-+ 50 
2wk 3 -  2 32 +_26 9±4 72.  +35 -3±9 -17±46 31_+11 147_+48 
4wk 4±2~ 39_+28 8±2 ¢~1 L31 l_+5t 6_+28 29 +9 139±44 
Reperfusion 11 ± 5+ 77 ÷ 2'4 17 + 5[ 82 _+ 22 
*p < 0.05, tp < 0.05, difference between groups. Data presented are mean value + SD. Base = % of baseline value; d = days; SS = segment shortening; WT = 
wall thickening. 
Echocardiographic analysis. The digitized images were 
displayed in a quad screen format. Myocardial thickening was 
defined as End-diastolic - End-systolic/End-diastolic thick- 
ness × 100%. Papillary muscles were used as a landmark to 
ensure the same location for all measurements over the various 
dobutamine studies and for comparison with preocclusion and 
reperfusion images. A total of three to five single values was 
averaged for each measurement. Measurements were obtained 
for preocclusion images, 1-h postocclusion images, each of the 
four dobutamine study images and reperfusion images. 
Sonomicrometric measurements. Sonomicrometric rys- 
tals were connected as previously described to a four-channel 
sonomicrometer module (Triton Technology, Inc.). Sonomi- 
crometer data, arterial and left ventricular pressures and ECG 
signals were recorded on an eight-channel Gould Brush re- 
corder and documented on 50 mm/s strip charts. The same 
data were also transferred on-line to a personal computer 
(Apple Macintosh IIFx; LabView Runtime software, National 
Instruments). Averaged data from a 30-s sampling interval 
were digitized for further storage and measurements. Segment 
shortening was calculated as End-diastolic - End-systolic/ 
End-diastolic segment length x 100%. The timing of sonomi- 
crometric measurements was done on day 4 using the dP/dt 
curves as time markers. By convention, end-diastole was 
defined as the onset of the initial upward deflection of the 
dP/dt signal and end-systole 25 ms before peak negative dP/dt. 
For the other dobutamine studies, end-diastole and end- 
systole were determined by the ECG tracing, as described 
previously, with the onset of the R wave as end-diastole and 
the end of the T wave as end-systole (15). 
Blood flow analysis. Radioactive microspheres were in- 
jected into the left atrial appendage after mechanical gitation 
of the solution. TwenW seconds before the injection, reference 
blood arterial samples for blood flow were withdrawn at a rate 
of 8 ml/min. Sliced myocardial tissue and reference blood 
samples were counted using a Hewlett-Packard series 5000 
multichannel analyzer. Tissue was measured in 1 × 1-cm 
samples both for the infarcted and normal zones. Counts 
emitted from the different isotopes were separated by a 
spectral stripping technique to calculate specific activity over 
the time periods. Myocardial blood flow was then calculated as 
follows: 
Myocardial b ood flow 
Tissue activity × Blood sample withdrawal rate 
Blood activity × Sample weight 
Statistics, Data are presented as mean value _+ SD. Anal- 
ysis of variance for repeated measures and the Newman-Keuls 
test were used for analysis of differences between values at 
baseline and after dobutamine administration, differences be- 
tween dobutamine doses and differences between the four 
different dobutamine studies. 
Results 
Dogs. Twenty-one dogs comprised the study group. Ligated 
vessels included the proximal left circumflex coronary artery in 
eight dogs, mid-left anterior descending coronary artery in four 
and proximal left anterior descending coronary artery in nine. Six 
dogs died within 48 h of initial operation, one after 1 week and 
one after 3 weeks. Coronary artery perfusion was successfully 
restored in 10 of the 13 remaining dogs. The results for the 10 
dogs with successful restoration of blood flow are presented. 
Seven dogs demonstrated improved function during dobut- 
amine infusion at all time points (group 1 [Table 1]). The 
remaining three dogs (group 2 [Table 2]) did not have an 
increase in myocardial thickening as assessed by echocardiog- 
raphy or sonomicrometric segment shortening during inotropic 
stimulation. Ligated coronary arteries in group 1 were the 
proximal left circumflex coronary artery in two dogs, mid-left 
anterior descending coronary artery in two and proximal left 
anterior descending coronary artery in three. The transmural 
extent of the infarcted area ranged from 20% to 70%. In group 
2, the ligated vessel in all dogs was the proximal left anterior 
descending coronary artery, and all had complete transmural 
infarction as assessed by staining with 1% triphenyltetrazolium 
chloride. 
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Table 2. Results for Group " 
Sonomicromet~' Echocardiography 
Baseline Dobutamine Baseline Dobutamine 
Study % SS % Base % SS % Base ~ WT % Base % WT % Base 
Preocclusion 16~3" 100 20 :3 '  1~ 
lh  -3±9*  -20+8 18:7" 93±39 
3d -3±5 -2(1±5 0±8 - I -5  -10±5 -46±14 
7d 3±8 -18±6 3±2 -4=15 -6±1 -33±5 
2wk ~+l  . . . .  11=8 11.32 ~ -0.6+12 -11+2 -55+8 
4wk 0.3:4? 1=2 0.6±0.4 3+2 9+3? 46+6 
Reperfusion l÷ l~ 8=7 -3+2?  14±14 
-3~2 16±6 
-4±2 -~±7 
-3±1 -19~7 
-6±4 -30±17 
*p < 0.05, tp < 0.05, difference between groups. Data presented are mean valuc= SD. Abbreviations as in Table 1. 
Sonomicrometric measurements. Group 1 (Table 1). 
Complete sonomicrometric data were obtained for four of 
seven dogs in group 1 (three were excluded because of crystal 
failure). Before occlusion, segment shortening was similar in 
both the control and ischemic zones (15 _+ 7% vs. 16 _+ 6% 
shortening, respectively, p = NS). After vessel igation, seg- 
ment shortening decreased in the ischemic zone (-3 _~ 3%, 
p = 0.008) but was unchanged inthe control zone (20 ~+ 11%, 
p = NS). During follow-up study, mean baseline segment 
shortening remained significantly suppressed compared with 
the preocclusion value. During dobutamine stimulation, seg- 
ment shortening increased significantly at each follow-up study 
compared with the baseline value of the same day, starting at 
a dose of 5 p~g/kg per min, except at the 2-week measurements, 
where a significant difference occurred at 2.5 ~g/kg per rain. 
Despite a trend toward less improvement with time, those 
differences did not reach statistical significance with regard to 
the degree of improvement between the four studies. After 
restoration of blood flow, segment shortening increased from 
4 + 2% to 11 _+ 5% (p < 0.05), a change from 39 _+ 28% of the 
initial preocclusion shortening (baseline after 4 weeks) to 
77 _+ 29% during the 1-h observation period (p = 0.09). After 
exclusion of dog 19 because of a 70% transmural infarction 
according to the analysis, segment shortening increased in the 
three remaining dogs from 51 _+ 24% to 96 + 11% (p < 0.07). 
Group 2 (Table 2). Complete sonomicrometric data were 
obtained for all three dogs in group 2, There was no significant 
difference in baseline values before occlusion between control 
and ischemic areas (13 + 2% vs. 16 _+ 3% segment shortening). 
During occlusion, segment shortening in the ischemic area 
decreased significantly to -3 _+ 9%, whereas the control area 
remained unchanged (12.5 _+ 1.5%, p = NS). During follow- 
up, analysis of segment shortening revealed persistent dyski- 
nesia at baseline studies as well as during dobutamine infusion. 
Exceptions were found during higher doses of dobutamine at
the 2-week study and at the final study when segment short- 
ening demonstrated small positive values close to the zero line 
with 0.3 _+ 4% shortening (1 _+ 2% of the preocclusion value). 
However, those changes were only marginal and did not reach 
significance. There was a significant change at dobutamine 
study 1 on day 3 after occlusion, with a change from -20 -+ 5~,i 
of the preocclusion value to less dyskinetic myocardial move- 
ment, but those values still demonstrated dyskinesia. After 
reperfusion, there was a small increase to 1 _+ 1% (8 _+ 7% of 
preocclusion shortening, p -- 0.4). 
Echocardiographic data. Group 1 (Table i). Complete 
echocardiographic data were obtained for all seven dogs at all 
study time points. Mean myocardial thickening was 21 _+ 3%. 
After ligation of the coronary artery, there was systolic thin- 
ning of the ischemia rea (mean -15 _+ 10%, p < 0.0001). 
During the follow-up period, myocardial wall thickening im- 
proved significantly during dobutamine infusion compared 
with that at baseline. When revascularization was performed, 
myocardial thickening increased significantly (from 1 _+ 5% to 
17 : 5%, p < 0.001). When expressed as percent of preocclu- 
sion function, the increase was from 6 _+ 28% to 82 + 22% 
during the 1-h follow-up period. The data for each animal are 
presented in Figure 2. 
Group 2 (Table 2). Complete chocardiographic data were 
obtained for all three dogs. After vessel occlusion, myocardial 
thickening decreased from 20 _+ 3% to -18 _+ 7%, p < 0.002). 
During dobutamine infusion, no significant improvement in
myocardial thickening was observed. After successful revascu- 
larization, no significant change in the infarcted area was seen. 
The data for each animal are presented in Figure 3. 
A summary of the maximal changes in segmental shorten- 
ing and wall thickening during dobutamine infusion at the 
various time points is depicted in Figure 4. 
Myocardial blood flow. Baseline myocardial blood flow at 4 
weeks demonstrated no significant differences in the control 
zone between groups 1 and 2 (204 _+ 115 vs. 136 _+ 93 ml/min 
per 100 g, respectively). Results for myocardial blood flow in 
the ischemic zone are presented in Figure 5. 
Infarct size. The transmural extent of infarction in group 1 
ranged from 20% to 70% (mean 34 _+ 16%). All dogs in group 
2 demonstrated transmural infarction (p < 0.0001). 
Discuss ion  
The present study demonstrated improvement in chroni- 
cally dysfunctional myocardium after restoration of previously 
interrupted myocardial blood flow in dogs undergoing a non- 
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Figure 2. Individual data for group 1 dogs. Thick solid line = percent wall thickening at
baseline, before coronary artery ligation; dashed line = percent wall thickening after coronary 
artery bypass. 
transmural myocardial infarction, thus validating a canine 
model of hibernating myocardium. In contrast, control dogs 
with complete transmural infarction demonstrated neither an 
increase in myocardial thickening nor segment shortening 
during dobutamine stimulation or any functional improve- 
ment after restoration of blood flow. In the dogs comprising 
group 1, we were able to demonstrate a persistent decrease in 
systolic function over a period of 4 weeks after ligation of a 
major coronary artery. Infusion of dobutamine r sulted in a 
significant increase in myocardial wall thickening and segment 
shortening ateach time point starting at a dobutamine infusion 
rate of 5 /~g/kg per rain. In addition, this recruitment of 
contractile reserve was reproducible after revascularization f 
the area supplied by the ligated vessel within 10 rain to 1 h after 
the bypass procedure. This finding was obtained only in those 
dogs that exhibited a nontransmural infarction as assessed by 
1% triphenyltetrazolium chloride staining. There was a trend 
toward spontaneous recovery both by echocardiographic as
well as by sonomicrometric measurements from a dyskinetic to 
a less dyskinetic or an akinetic/hypokinetic myocardial function 
over the period of the study. 
This finding has been reported 16.17) and is most likely 
due to the canine ability to rapidly recruit collateral flow. 
However, the values measured after 4 weeks were still signif- 
icantly decreased compared with those for initial function and 
demonstrated potentially contractile myocardium during do- 
butamine infusion as well as contractile improvement after 
flow augmentation by bypassing the ligated vessel. There was a 
trend toward the largest extent of contractile reserve during 
the early dobutamine study, with less improvement a the late 
study, but these differences did not reach significance, probably 
due to the small number of dogs studied. Dogs in group 1 did 
differ when considered individually. For example, dog 10, with 
a 25% transmural infarction, recovered spontaneously after 4 
weeks to 50% of initial echocardiographie thickening, or 65% 
of sonomicrometric shortening, and showed an additional 
increase after reperfusion up to 100% of initial thickening 
(82% shortening). In contrast, dog 19, with a 70% transmural 
infarction, demonstrated myocardial function that was still 
dyskinetic after 4 weeks (-4% thickening, 0.5% shortening) 
and myocardial function increased after reperfusion to 56% 
thickening (29% shortening). All dogs in group 2 with a 100% 
transmura] infarction demonstrated either no or minimal 
improvement, from severe to moderate dyskinesis, probably 
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Figure 3. Individual data for group 2 dogs. Symbols as in Figure 2. 
due to an unloading effect during dobutamine infusion. These 
dogs did not show any significant improvement after revascu- 
larization. Our findings suggest that in the absence of a 
transmural infarction, apreserved contractile reserve xists for 
at least 4 weeks after infarction. 
Comparison with previous studies. The exact mechanism 
of this down-regulation f function remains unclear. However, 
some changes in myocardial cell metabolism are known. Ex- 
perimental nimal models as well as positron emission tomo- 
graphic studies in humans describe a switch from myocardial 
energy production ormally fueled by free fatty acids to an 
enhanced uptake of free glucose and lactate release. Schulz et 
al. (18) found lactate production closely linked to flow reduc- 
tion and demonstrated a stable state after a relatively short 
period of ischemia, without further eduction of intracellular 
glycogen storage, suggesting an early switch to anaerobic 
metabolism utilizing exogenous glucose. Schulz et al. used 
dobutamine in a model of short hibernation and were able to 
improve contractile function but at the cost of increasing 
lactate release and further depletion of glycogen stores. How- 
I - - ' -  a uP 2 I 20 
U) O -10 
-20 
, _ _  . . . .  , , 
BASE UGATE DAY 3 1 WEEK 2 WEEK 4 WEEK REPER 
STAG ES 
50-  
z 
w 
_9 O- -r 
I -  
/ 
~ -5o 
- GROUP 1 
, GROUP 2 
I I I I I I I 
BASE LIGATE DAY 3 I WEEK 2 WEEK 4 WEEK REPER 
STAGES 
Figure 4. Percent segment shortening (top) and percent wall thicken- 
ing (bottom) versus time. Data shown are mean peak response to 
dobutamine infusion (solid symbols) _+ SE (error bars) for each stage. 
BASE = baseline; LIGATE = coronary artery ligation; REPER = reper- 
fusion by coronary bypass. * p < 0.001. 
ever, their model included ischemic periods up to 90 min only 
and cannot be directly compared with our investigation using 
flow down-regulation ver 4 weeks. 
Pierard et al. (19) compared positron emission tomographic 
imaging with dobutamine echocardiography to assess tunned 
myocardium. They investigated 17 patients after thrombolytic 
treatment for acute myocardial infarction and found a corre- 
lation between viable segments by dobutamine echocardiogra- 
phy and those by positron emission tomographic-metabolism 
results. After a follow-up period of 9 % 7 months, there was 
also close correlation between segments identified as viable in 
the acute setting and long-term recovery of segmental func- 
tion. 
Cigarroa et al. (13) investigated 25 patients with multivessel 
coronary, artery disease and depressed myocardial function in 
the absence of a recent myocardial infarction. Of 11 patients 
who demonstrated improved systolic thickening during dobut- 
amine echocardiography, 9 also showed improved systolic 
thickening 4 weeks after successful coronary bypass urgery. 
Clincal studies from additional centers have evaluated both 
low and high dose dobutamine stress echocardiography in 
patients with left ventricular dysfunction before coronary 
artery revascularization (14,20). Afridi et al. (20) found that 
low as well as high dose dobutamine administration was 
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Figure 5. Myocardial b ood flow at baseline and at 30-#g/kg per mm 
dobutamine infusion. 
necessary for optimal identification of patients with hibernat- 
ing myocardium (20). 
Our canine model supports the observations seen in the 
clinical setting. However, a major difference xists with 
regard to the method of assessing myocardial segmental 
function. The clinical investigators used a semiquantitative 
scoring system involving a 16-segment model of different 
echocardiographic views. Improvement was defined subjec- 
tively, with hypokinetic segments becoming more normal, or 
akinetic segments becoming hypokinetic. In contrast, we 
performed quantitative measurements u ing two indepen- 
dent methods. Myocardial wall thickening was measured at 
a defined point of interest over the study period. In addition, 
we used implanted sonomicrometer c ystals to measure 
changes in segmental shortening in the infarcted as well as 
the control area. The results of both methods were concor- 
dant during dobutamine stimulation as well as during the 
observation period after reperfusion. 
Our study allowed determination f myocardial function 
during dobutamine administration at several time points 
over the course of 4 weeks. Myocardial function was as- 
sessed uring dobutamine infusion rates of 2.5 to 30 ~g/kg 
per rain. Myocardial function began to improve at doses as 
low as 5 tzg/kg per rain and improvement persisted at doses 
as high as 30/sg/kg per min. Some improvement in myocar- 
dial function was even seen in areas with up to 70% 
transmural infarction. 
Limitations of the study. The present study is limited by 
the small number of dogs that completed the entire study 
protocol. Failure of the crystals over time in some group 1 
animals limited the available sonomicrometric measure- 
ments. The present study focused on contractile myocardial 
function and did not assess tissue structure in the ischemic 
area by histologic methods, which might have contributed to
a further understanding of the changes in myocardial func- 
tion during dobutamine infusion and after evascularization. 
We did not measure metabolic markers on the cellular level, 
which might have provided further information regarding 
the basic physiology of myocardial hibernation. Our defini- 
tion of hibernation was based on contractile function; thus, 
we cannot exclude the possibility that noncontractile myo- 
cardium in group 2 dogs may potentially be viable at the 
metabolic or cellular level. Finally, in humans, we would 
expect hat at high doses of dobutamine, some but not all 
patients would demonstrate evidence of ischemia (worsen- 
ing of function) (20). The lack of ischemic response in our 
series of dogs may be a reflection of sample size or possibly 
adequate collateral flow that is recruited as a result of 
stimulation by dobutamine. 
Clinical implications. The presence of contractile reserve 
could be predicted by dobutamine stimulation at various time 
points over the study period. The present data support obser- 
vations in patients demonstrating the ability of dobutamine 
echocardiography to identify hibernating myocardium. An 
animal model of hibernating myocardium has been estab- 
lished. The effects of a variety of pharmacologic interventions 
may be assessed using this model. 
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